# D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD

> **NCT01172873** · NA · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 16 (actual)

## Conditions studied

- Obsessive Compulsive Disorder

## Interventions

- **DRUG:** D-cycloserine
- **BEHAVIORAL:** Exposure and Response Prevention (EX/RP)

## Key facts

- **NCT ID:** NCT01172873
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-09
- **Final completion:** 2010-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2014-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01172873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01172873, "D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT01172873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*